| 000 | 01658 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517004427.0 | ||
| 264 | 0 | _c20150825 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1558-0474 | ||
| 024 | 7 |
_a10.1016/j.ogc.2014.08.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurtha, Amy P | |
| 245 | 0 | 0 |
_aThe role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. _h[electronic resource] |
| 260 |
_bObstetrics and gynecology clinics of North America _cDec 2014 |
||
| 300 |
_a615-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aChorioamnionitis _xmicrobiology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetal Membranes, Premature Rupture _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfant, Premature, Diseases _xepidemiology |
| 650 | 0 | 4 |
_aMycoplasma _xisolation & purification |
| 650 | 0 | 4 |
_aMycoplasma Infections _xepidemiology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xepidemiology |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aPremature Birth _xmicrobiology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aUreaplasma _xisolation & purification |
| 650 | 0 | 4 |
_aUreaplasma Infections _xepidemiology |
| 650 | 0 | 4 |
_aVagina _xmicrobiology |
| 700 | 1 | _aEdwards, James M | |
| 773 | 0 |
_tObstetrics and gynecology clinics of North America _gvol. 41 _gno. 4 _gp. 615-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ogc.2014.08.010 _zAvailable from publisher's website |
| 999 |
_c24409386 _d24409386 |
||